Multiple Sclerosis Trial, By Invitation NCT07074587 Sponsor: Abant Izzet Baysal University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT07074587
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women between the ages of 18 and 65 years
  • People who have been diagnosed with Multiple Sclerosis by a specialist neurologist and also have bladder symptoms, specifically a score of 9 or higher on the Overactive Bladder-V8 scale and at least two of the following: leaking urine, needing to urinate during the night, going to the toilet more than 8 times during the day, a sudden strong urge to urinate, stopping and starting while urinating, a slow urine stream, or a feeling that the bladder has not fully emptied
  • People whose MS is in a mild or moderate stage, meaning a score below 6 on a standard MS disability scale (EDSS)
  • People who have not had an MS relapse in the past month
  • People who score 24 or above on a standard memory and thinking assessment (Mini-Mental State Examination)
  • People who are able to read and write
  • People who are willing to take part in the study voluntarily
  • People who are able to consciously squeeze and control their pelvic floor muscles
  • People whose medications have not changed in the past three months
  • People who are able to understand and actively take part in the assessments and activities involved in the study

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with one or more neurological conditions in addition to Multiple Sclerosis
  • People with a Body Mass Index (BMI) of 30 or higher
  • People who have been diagnosed with overflow urinary incontinence (a type of bladder condition where the bladder does not empty properly and leaks)
  • People who have previously used a type of bladder medication called antimuscarinics
  • People who have advanced pelvic organ prolapse (stage 2 or higher), a condition where pelvic organs have shifted out of their normal position
  • People who currently have a urinary tract infection
  • People who have had a caesarean section or vaginal birth in the past 6 months
  • People who have any other neurological condition that may be causing urinary leakage
  • People who have had surgery involving the urinary or reproductive system
  • People who have a history of cancer
  • People who are currently pregnant or who are not sexually active (confirm with trial site)
  • People who have taken part in exercise training or physical therapy for bladder symptoms within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Abant Izzet Baysal University
Registry
ClinicalTrials.gov
Start date
30 June 2025
Est. completion
15 October 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Evaluation of Urinary Symptoms; Evaluation of Bladder Functions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov